TGF-β1 levels are significantly elevated in the synovial fluid and tissues of RA patients, where it contributes to disease progression by promoting fibroblast proliferation, synovial hypertrophy, and extracellular matrix degradation (Bira et al. 2005; Cheon et al. 2002). This evidence concerns the gene TGFB1 and rheumatoid arthritis.